Akanda Corp.

Equities

AKAN

CA00971M2058

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.103 ^USD	+12.57%		+9.11%	-76.62%

Apr. 26	Akanda Corp. Announces Board Changes	CI
Apr. 12	Akanda Corp. Announces Commercialize and Capitalize on Germany?s Legalization of Cannabis, Opening Path to $3 billion Market and Plans to Enter Blockchain and AI Technology Sector	CI

Akanda Corp. Reports Earnings Results for the Half Year Ended June 30, 2023

December 29, 2023 at 05:28 pm EST

Akanda Corp. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was USD 1.4 million compared to USD 0.073096 million a year ago.

Net loss was USD 5.88 million compared to USD 2.59 million a year ago. Basic loss per share from continuing operations was USD 1.46 compared to basic earnings per share from continuing operations of USD 0.43 a year ago. Diluted loss per share from continuing operations was USD 1.46 compared to diluted earnings per share from continuing operations of USD 0.43 a year ago.

Basic loss per share was USD 1.46 compared to USD 0.97 a year ago. Diluted loss per share was USD 1.46 compared to USD 0.97 a year ago.

Latest news about Akanda Corp.

Akanda Corp. Announces Board Changes	Apr. 26	CI
Akanda Corp. Announces Commercialize and Capitalize on Germany?s Legalization of Cannabis, Opening Path to $3 billion Market and Plans to Enter Blockchain and AI Technology Sector	Apr. 12	CI
Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of Cannabis Market	Mar. 28	CI
SOMAI Pharmaceuticals Inc. entered into Non-Binding Letter of Intent to acquire Rpk Biopharma, Unipessoal, Lda from Akanda Corp. for ?1.85 million.	Feb. 01	CI
Akanda Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	Dec. 29	CI
Akanda Hires Charn Deol as CFO	Dec. 12	MT
Akanda Corp. Appoints Charn Deol as Chief Financial Officer	Dec. 11	CI
Akanda Gets Nasdaq Notice on Minimum Bid Price Deficiency	23-07-06	MT
Akanda Corp. Announces Termination of Loan Agreement	23-05-30	CI
Akanda Terminates Loan Agreement With Veridia Canada	23-05-30	MT
Akanda Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-02	CI
Akanda Corp. Auditor Raises 'Going Concern' Doubt	23-05-01	CI
Akanda Corp. Announces That It Has Entered into A Loan Agreement with Veridia Canada Ltd	23-05-01	CI
Akanda Regains Compliance With Nasdaq Listing Requirements	23-03-29	MT
Certain Common Shares of Akanda Corp. are subject to a Lock-Up Agreement Ending on 14-MAR-2023.	23-03-13	CI
Akanda Plans 1-for-10 Reverse Stock Split; Shares Fall	23-03-08	MT
North American Morning Briefing : Stock Futures -2-	23-03-08	DJ
Akanda Names Shailesh Bhushan Finance Chief	23-03-08	MT
Akanda Corporation Announces Appointment of Shailesh Bhushan as Chief Financial Officer	23-03-07	CI
Akanda Corp. Announces Board Changes	23-02-16	CI
Akanda Corp. Announces Executive Changes	23-02-07	CI
Akanda Corp. Announces Directorate Changes	23-02-07	CI
Top Premarket Gainers	23-01-27	MT
Top Premarket Gainers	23-01-20	MT
Akanda Corp. Reports Earnings Results for the Half Year Ended June 30, 2022	23-01-04	CI

Chart Akanda Corp.

Duration

Period

More charts

Company Profile

Akanda Corp. is an international medical cannabis and wellness platform company. The Companyâs portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The Company also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Sector Medical Farming

	1st Jan change	Capi.
AKANDA CORP.	-76.62%	872K
ASCEND WELLNESS HOLDINGS, INC.	+31.96%	272M
AYR WELLNESS INC.	+33.74%	261M
ORGANIGRAM HOLDINGS INC.	+49.42%	194M
JUSHI HOLDINGS INC.	+44.98%	131M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
INTERCURE LTD.	+115.91%	119M
THE CANNABIST COMPANY HOLDINGS INC.	-42.17%	119M
4FRONT VENTURES CORP.	0.00%	86.82M
BAKHU HOLDINGS, CORP.	+150.00%	75.33M

Medical Farming